{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:36Z","timestamp":1786984296525,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.amjcard.2016.08.016","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T13:54:58Z","timestamp":1472133298000},"page":"1497-1502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Usefulness of Atrial Fibrillation as a Marker for Adverse Cardiovascular Outcomes in Both Primary and Secondary Prevention in Patients With Implantable Cardioverter-Defibrillators"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6984-4023","authenticated-orcid":false,"given":"Ian C.Y.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf M.","family":"Agamawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne O.","family":"Adkisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Roukoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa N.","family":"von Wald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Benditt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2016.08.016_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.08.016_bib2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.08.016_bib3","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A\u00a0comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. the Antiarrhythmics Versus Implantable Defibrillators (AVID) investigators","volume":"337","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.08.016_bib4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/europace\/euq329","article-title":"Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis","volume":"12","author":"Theuns","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2016.08.016_bib5","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1161\/CIRCUALTIONAHA.108.189742","volume":"117","author":"Epstein","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.08.016_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1161\/CIR.0000000000000056","article-title":"HRS\/ACC\/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials","volume":"130","author":"Kusumoto","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.08.016_bib7","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.jacc.2007.02.058","article-title":"Effect of cardiac and noncardiac conditions on survival after defibrillator implantation","volume":"49","author":"Lee","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.08.016_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1540-8159.2007.00651.x","article-title":"Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death","volume":"30","author":"Cuculich","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2016.08.016_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/europace\/euq328","article-title":"The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality","volume":"13","author":"Theuns","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2016.08.016_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.ajkd.2013.12.009","article-title":"Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials","volume":"64","author":"Pun","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2016.08.016_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ahj.2005.04.009","article-title":"Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection","volume":"151","author":"Parkash","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2016.08.016_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.hrthm.2008.12.023","article-title":"Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators","volume":"6","author":"Cygankiewicz","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2016.08.016_bib13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.08.016_bib14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.08.016_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/heartjnl-2013-305002","article-title":"Application of a mortality risk score in a general population of patients with an implantable cardioverter defibrillator (ICD)","volume":"100","author":"Schaer","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2016.08.016_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jacc.2007.08.058","article-title":"Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction","volume":"51","author":"Goldenberg","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.08.016_bib17","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jacc.2007.04.095","article-title":"Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study","volume":"50","author":"Buxton","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.08.016_bib18","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jacc.2012.02.036","article-title":"Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator","volume":"59","author":"Barsheshet","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.08.016_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jchf.2014.06.007","article-title":"Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials","volume":"2","author":"Steinberg","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2016.08.016_bib20","first-page":"218","article-title":"Predictors of mortality amongst recipients of implantable cardioverter defibrillators for secondary prevention of cardiac arrest","volume":"7","author":"Agarwal","year":"2007","journal-title":"Indian Pacing Electrophysiol J"},{"key":"10.1016\/j.amjcard.2016.08.016_bib21","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1161\/CIRCULATIONAHA.104.526673","article-title":"Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial","volume":"111","author":"Sweeney","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.08.016_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/europace\/euq494","article-title":"Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients","volume":"13","author":"van Welsenes","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2016.08.016_bib23","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2016.08.016_bib24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.08.016_bib25","doi-asserted-by":"crossref","first-page":"68D","DOI":"10.1016\/S0002-9149(98)01006-6","article-title":"Secondary prevention of sudden death: the Dutch study, the antiarrhythmics versus implantable defibrillator trial, the cardiac arrest study Hamburg, and the Canadian Implantable Defibrillator Study","volume":"83","author":"Cappato","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2016.08.016_bib26","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1111\/j.1540-8159.2006.00489.x","article-title":"Atrial tachyarrhythmias in primary and secondary prevention ICD recipients: clinical and prognostic data","volume":"29 Suppl 2","author":"Botto","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2016.08.016_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.hrthm.2008.09.025","article-title":"Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality","volume":"6","author":"Bunch","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2016.08.016_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccl.2008.09.014","article-title":"Atrial fibrillation in patients with implantable defibrillators","volume":"27","author":"Sakhuja","year":"2009","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.amjcard.2016.08.016_bib29","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1253\/circj.CJ-14-0814","article-title":"Atrial fibrillation and its association with sudden cardiac death","volume":"78","author":"Chen","year":"2014","journal-title":"Circ J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916313765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916313765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T21:23:34Z","timestamp":1536441814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914916313765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0002914916313765"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.08.016","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of Atrial Fibrillation as a Marker for Adverse Cardiovascular Outcomes in Both Primary and Secondary Prevention in Patients With Implantable Cardioverter-Defibrillators","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}